ArticleFrontiers in computational neuroscience2025
AD-Diff: enhancing Alzheimer's disease prediction accuracy through multimodal fusion.
Article in Frontiers in computational neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- AutoML-Multiverse: An Instability-Aware Framework for Quantifying Analytic Variability in Alzheimer's Disease Machine-Learning Studies.medRxiv : the preprint server for health sciences · 2026Article
- NeuroFusion-ViT: A Hybrid CNN-EVA Transformer Model with Cross-Attention Fusion for MRI-Based Alzheimer's Stage Classification.Diagnostics (Basel, Switzerland) · 2026Article
- HyperTransFusion: a hypernetwork transformer with black winged kite optimization for multimodal early Alzheimer's disease diagnosis.Frontiers in digital health · 2026Article
- Investigating Alzheimer's Disease Progression Using a Radiomics Approach: The Hippocampal-Amygdala Border in FDG-Positron Emission Tomography Scans.Neuro-degenerative diseases · 2026Article
- Designing implicit population learners: a permutation-equivariant state space approach for brain disease diagnosis.Frontiers in computational neuroscience · 2026Article
- Gender-based Alzheimer's detection using ResNet-50 and binary dragonfly algorithm on neuroimaging.Frontiers in artificial intelligence · 2025Article
Corrections and comments
- Retracted
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early prediction of Alzheimer's disease (AD) is crucial to improving patient quality of life and treatment outcomes. However, current predictive methods face challenges such as insufficient multimodal information integration and the high cost of PET image acquisition, which limit their effectiveness in practical applications. To address these issues, this paper proposes an innovative model, AD-Diff. This model significantly improves AD prediction accuracy by integrating PET images generated through a diffusion process with cognitive scale data and other modalities. Specifically, the AD-Diff model consists of two core components: the ADdiffusion module and the multimodal Mamba Classifier. The ADdiffusion module uses a 3D diffusion process to generate high-quality PET images, which are then fused with MRI images and tabular data to provide input for the Multimodal Mamba Classifier. Experimental results on the OASIS and ADNI datasets demonstrate that the AD-Diff model performs exceptionally well in both long-term and short-term AD prediction tasks, significantly improving prediction accuracy and reliability. These results highlight the significant advantages of the AD-Diff model in handling complex medical image data and multimodal information, providing an effective tool for the early diagnosis and personalized treatment of Alzheimer's disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.